Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyaluronic acid supplementation.

R W Moskowitz1

  • 1Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, USA. RWM3@po.cwru.edu

Current Rheumatology Reports
|December 21, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Introduction to OARSI FDA initiative OAC special edition.

Osteoarthritis and cartilage·2011
Same author

A walking model to assess the onset of analgesia in osteoarthritis knee pain.

Osteoarthritis and cartilage·2010
Same author

OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009.

Osteoarthritis and cartilage·2010
Same author

Absence of association of asporin polymorphisms and osteoarthritis susceptibility in US Caucasians.

Osteoarthritis and cartilage·2008
Same author

OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines.

Osteoarthritis and cartilage·2008
Same author

OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence.

Osteoarthritis and cartilage·2007
Same journal

Type I Interferonopathies: Fifteen Years On, From Concept to Therapeutic Perspectives.

Current rheumatology reports·2026
Same journal

Intensive Care Management of ANCA-associated Vasculitides: a Narrative Review.

Current rheumatology reports·2026
Same journal

The Role of Musculoskeletal Ultrasound in Psoriatic Arthritis: From Preclinical Detection to Treatment Monitoring.

Current rheumatology reports·2026
Same journal

Correction to: Is Gout and Autoinflammatory Disease?

Current rheumatology reports·2026
Same journal

Risks and Management of Glucocorticoid Therapy for Patients with Rheumatic Disease Having Surgery.

Current rheumatology reports·2026
Same journal

Perioperative Management Considerations for Patients with Systemic Lupus Erythematosus.

Current rheumatology reports·2026
See all related articles

New guidelines reflect significant changes in osteoarthritis (OA) management. Intra-articular hyaluronan (HA) injections offer pain relief and improved function for knee OA patients, potentially modifying disease structure.

Area of Science:

  • Rheumatology
  • Biochemistry

Background:

  • Osteoarthritis (OA) management is evolving, with new guidelines reflecting updated therapeutic options.
  • Cyclo-oxygenase-2 inhibitors and intra-articular hyaluronans (HA) are emerging treatments.
  • In OA, hyaluronan (HA) exhibits decreased molecular weight and concentration, impairing synovial fluid viscoelasticity.

Purpose of the Study:

  • To review the role and therapeutic mechanisms of intra-articular hyaluronan (HA) in osteoarthritis (OA) management.
  • To highlight HA's potential structure-modifying effects in OA.

Main Methods:

  • Review of current literature on osteoarthritis treatments, focusing on hyaluronan (HA) preparations.
  • Analysis of studies investigating HA's efficacy, mechanisms, and potential structure-modifying properties in OA models and human subjects.

Related Experiment Videos

Main Results:

  • Intra-articular hyaluronan (HA) preparations effectively reduce pain and enhance function in knee osteoarthritis (OA).
  • Therapeutic mechanisms include restoring synovial fluid viscoelasticity, influencing cartilage metabolism, exerting anti-inflammatory effects, and providing analgesia.
  • Preliminary evidence suggests HA may possess structure-modifying capabilities in OA.

Conclusions:

  • Hyaluronan (HA) represents a significant advancement in the therapeutic options for managing osteoarthritis (OA).
  • Further research into HA's structure-modifying potential is warranted.